ATRX OTC
Adhera Therapeutics Inc
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -99.0%
3Y: -99.5%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$1M
-112.8% ▼
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$1M
-112.8% ▼
Dividends Paid
$0
+100.0% ▲
Buybacks
$2K
+99.7% ▲
Net Change in Cash
-$44K
-159.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$17M | -$12M | -$4M | -$6M | -$2M |
| Depreciation & Amort. | $333K | $82K | $400K | $398K | $0 |
| Stock-Based Comp. | $1M | $765K | $8K | $0 | $0 |
| Change in Working Capital | -$1M | $480K | $1M | $9K | $203K |
| Other Non-Cash Items | $600K | $679K | $2M | $5M | $496K |
| Operating Cash Flow | -$10M | -$9M | -$588K | -$665K | -$1M |
| — Investing Activities — | |||||
| Capital Expenditures | -$74K | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$74K | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$74K | $0 | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $539K | $739K | $2M |
| Stock Repurchased | -$250K | -$100K | -$539K | -$739K | -$2K |
| Dividends Paid | -$1M | -$2M | -$2M | -$2M | $0 |
| Other Financing | $921K | $6M | $2M | $2M | -$346K |
| Financing Cash Flow | $13M | $5M | $539K | $739K | $1M |
| Net Change in Cash | $4M | -$4M | -$49K | $74K | -$44K |
| Cash End of Period | $4M | $50K | $1K | $75K | $32K |
| Free Cash Flow | -$10M | -$9M | -$588K | -$665K | -$1M |